Thread by @BethWaldron

Non-medical drug switching--born not of clinical reasons but out of the revenue-maximizing contract negotiations between pharma & PBMs--has tangible human impact. I am one of those impacted. #CardioTwitter #StopTheSwitch #MedTwitter #TwitterRx onlinelibrary.wiley.com/doi/full/10.10…

2) Shared decision making necessitates that no one stand between a patient & clinician making decisions based upon the clinical evidence.
yet
Non-medical drug switching= the insurance PBM knows better than patient & doctor.
#MedTwitter #CardioTwitter #TwitterRx #StopTheSwitch

3) If clinical evidence cannot be acted upon at the point of care at the dictates of a profit-motivated third party, can clinicians really be said to be practicing evidenced-based medicine?
🚨Clinical decisions MUST be between a patient & physician only.#MedTwitter #CardioTwitter

4) Anticoagulants are the #1 class of drugs for adverse events. They require careful clinical management. I trust my doctor of 18 years to manage my anticoagulant therapy, not my insurance PBM, who is motivated by nontransparent profit motives. #CardioTwitter #MedTwitter

5) Federal prohibition of non-medical switching is needed. Allowing a corporation to override a physician's order, switching stable heart patients off a drug they've taken for YEARS? The lack of protections to prevent patient harm is astonishing. @SenFinance @FTC @WaysMeansCmte